Chesney, C M <br/><br/>
Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets.  [electronic resource] 

 -  Biochemical and biophysical research communications  Apr 1987 
 - 359-66 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0006-291X 
<br/><br/><label>Standard No.: </label>10.1016/s0006-291x(87)80518-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alprazolam--metabolism<br/>Binding, Competitive<br/>Blood Platelets--drug effects<br/>Diazepam--metabolism<br/>Humans<br/>In Vitro Techniques<br/>Kinetics<br/>Platelet Activating Factor--metabolism<br/>Platelet Aggregation--drug effects<br/>Triazolam--metabolism